triamterene and hydrochlorothiazide

Generic: triamterene and hydrochlorothiazide

Labeler: macleods pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name triamterene and hydrochlorothiazide
Generic Name triamterene and hydrochlorothiazide
Labeler macleods pharmaceuticals limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

hydrochlorothiazide 25 mg/1, triamterene 37.5 mg/1

Manufacturer
Macleods Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 33342-467
Product ID 33342-467_96024781-b8d8-452f-ab9c-6c9ab07b34ea
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214611
Listing Expiration 2026-12-31
Marketing Start 2025-01-28

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc] potassium-sparing diuretic [epc]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe] decreased renal k+ excretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 33342467
Hyphenated Format 33342-467

Supplemental Identifiers

RxCUI
198316
UPC
0333342467119 0333342467447
UNII
0J48LPH2TH WS821Z52LQ
NUI
N0000175359 N0000175419 M0471776 N0000008859 N0000175418

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name triamterene and hydrochlorothiazide (source: ndc)
Generic Name triamterene and hydrochlorothiazide (source: ndc)
Application Number ANDA214611 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
  • 37.5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (33342-467-11)
  • 1000 CAPSULE in 1 BOTTLE (33342-467-44)
source: ndc

Packages (2)

Ingredients (2)

hydrochlorothiazide (25 mg/1) triamterene (37.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "96024781-b8d8-452f-ab9c-6c9ab07b34ea", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000008859", "N0000175418"], "upc": ["0333342467119", "0333342467447"], "unii": ["0J48LPH2TH", "WS821Z52LQ"], "rxcui": ["198316"], "spl_set_id": ["e05e3314-5520-4bbd-b7f0-623afd9ba569"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]", "Decreased Renal K+ Excretion [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Potassium-sparing Diuretic [EPC]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (33342-467-11)", "package_ndc": "33342-467-11", "marketing_start_date": "20250128"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (33342-467-44)", "package_ndc": "33342-467-44", "marketing_start_date": "20250128"}], "brand_name": "Triamterene and Hydrochlorothiazide", "product_id": "33342-467_96024781-b8d8-452f-ab9c-6c9ab07b34ea", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Renal K+ Excretion [PE]", "Increased Diuresis [PE]", "Increased Diuresis [PE]", "Potassium-sparing Diuretic [EPC]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "33342-467", "generic_name": "Triamterene and Hydrochlorothiazide", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triamterene and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "TRIAMTERENE", "strength": "37.5 mg/1"}], "application_number": "ANDA214611", "marketing_category": "ANDA", "marketing_start_date": "20250128", "listing_expiration_date": "20261231"}